BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 27183639)

  • 1. NK Cells Help Induce Anti-Hepatitis B Virus CD8+ T Cell Immunity in Mice.
    Zheng M; Sun R; Wei H; Tian Z
    J Immunol; 2016 May; 196(10):4122-31. PubMed ID: 27183639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-15 suppresses hepatitis B virus replication via IFN-β production in a C57BL/6 mouse model.
    Yin W; Xu L; Sun R; Wei H; Tian Z
    Liver Int; 2012 Sep; 32(8):1306-14. PubMed ID: 22380514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
    Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
    J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. γδT cells drive myeloid-derived suppressor cell-mediated CD8+ T cell exhaustion in hepatitis B virus-induced immunotolerance.
    Kong X; Sun R; Chen Y; Wei H; Tian Z
    J Immunol; 2014 Aug; 193(4):1645-53. PubMed ID: 25015833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice.
    Krebs K; Böttinger N; Huang LR; Chmielewski M; Arzberger S; Gasteiger G; Jäger C; Schmitt E; Bohne F; Aichler M; Uckert W; Abken H; Heikenwalder M; Knolle P; Protzer U
    Gastroenterology; 2013 Aug; 145(2):456-65. PubMed ID: 23639914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
    Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C
    Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.
    Fisicaro P; Valdatta C; Boni C; Massari M; Mori C; Zerbini A; Orlandini A; Sacchelli L; Missale G; Ferrari C
    Gut; 2009 Jul; 58(7):974-82. PubMed ID: 19201769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kupffer Cells Support Hepatitis B Virus-Mediated CD8+ T Cell Exhaustion via Hepatitis B Core Antigen-TLR2 Interactions in Mice.
    Li M; Sun R; Xu L; Yin W; Chen Y; Zheng X; Lian Z; Wei H; Tian Z
    J Immunol; 2015 Oct; 195(7):3100-9. PubMed ID: 26304988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of hepatitis B virus mRNA expression in a hepatitis B surface antigen transgenic mouse model by IFN-gamma-secreting T cells after DNA-based immunization.
    Mancini M; Hadchouel M; Tiollais P; Michel ML
    J Immunol; 1998 Nov; 161(10):5564-70. PubMed ID: 9820533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell activation contributes to hepatitis B viral control in a mouse model.
    Tong S; Liu G; Li M; Li X; Liu Q; Peng H; Li S; Ren H; Yin W
    Sci Rep; 2017 Mar; 7(1):314. PubMed ID: 28331190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD27low natural killer cells prolong allograft survival in mice by controlling alloreactive CD8+ T cells in a T-bet-dependent manner.
    Lantow M; Eggenhofer E; Sabet-Baktach M; Renner P; Rovira J; Koehl GE; Schlitt HJ; Geissler EK; Kroemer A
    Transplantation; 2015 Feb; 99(2):391-9. PubMed ID: 25606781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice.
    Peng XH; Ren XN; Chen LX; Shi BS; Xu CH; Fang Z; Liu X; Chen JL; Zhang XN; Hu YW; Zhou XH
    World J Gastroenterol; 2015 Mar; 21(12):3527-36. PubMed ID: 25834317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer T cell activation inhibits hepatitis B virus replication in vivo.
    Kakimi K; Guidotti LG; Koezuka Y; Chisari FV
    J Exp Med; 2000 Oct; 192(7):921-30. PubMed ID: 11015434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic decrease in PD-1 expression correlates with HBV-specific memory CD8 T-cell development in acute self-limited hepatitis B patients.
    Zhang Z; Jin B; Zhang JY; Xu B; Wang H; Shi M; Wherry EJ; Lau GK; Wang FS
    J Hepatol; 2009 Jun; 50(6):1163-73. PubMed ID: 19395117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-21-based therapies induce clearance of hepatitis B virus persistence in mouse models.
    Shen Z; Liu J; Wu J; Zhu Y; Li G; Wang J; Luo M; Deng Q; Zhang J; Xie Y
    Theranostics; 2019; 9(13):3798-3811. PubMed ID: 31281514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK cells contribute to hepatic CD8
    Jiang S; Zhu Y; Cheng C; Li Y; Ma T; Peng Z; Li Q; Xu J; Xu L
    Virus Res; 2020 Sep; 286():198085. PubMed ID: 32622853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
    Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK cells regulate CD8+ T cell priming and dendritic cell migration during influenza A infection by IFN-γ and perforin-dependent mechanisms.
    Ge MQ; Ho AW; Tang Y; Wong KH; Chua BY; Gasser S; Kemeny DM
    J Immunol; 2012 Sep; 189(5):2099-109. PubMed ID: 22869906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection.
    Conroy MJ; Mac Nicholas R; Grealy R; Taylor M; Otegbayo JA; O'Dea S; Mulcahy F; Ryan T; Norris S; Doherty DG
    J Viral Hepat; 2015 Mar; 22(3):335-45. PubMed ID: 25186004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo acute depletion of CD8(+) T cells before murine cytomegalovirus infection upregulated innate antiviral activity of natural killer cells.
    Salem ML; Hossain MS
    Int J Immunopharmacol; 2000 Sep; 22(9):707-18. PubMed ID: 10884591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.